
Articles
-
5 days ago |
asiainsurancereview.com | Reva Ganesan
Speaking at a skill enhancement programme held in Kathmandu for AML/CFT implementation officers from various insurers, Mr Ojha urged participants to prepare and update their internal policies and strategies in accordance with the guidelines and directives issued by the Authority to effectively address money laundering risks.
-
5 days ago |
asiainsurancereview.com | Reva Ganesan
Countries like Australia and Korea have well-established surety markets, and the use of surety as a guarantee solution is expected to grow significantly in other parts of Asia, particularly in China and India, fuelled by economic expansion and accelerating infrastructure development, the report said. The infrastructure investment need in the region is expected to be $1.7tn annually up until 2030.
-
5 days ago |
asiainsurancereview.com | Reva Ganesan
US- based private equity firm Warburg Pincus is reportedly in discussions to sell its 10% stake in SBI General Insurance, the general insurance arm of State Bank of India, according to a Bloomberg News report, citing sources familiar with the matter. The firm is said to be negotiating with Premji Invest—the investment vehicle of Indian billionaire Azim Premji—and SBI, India’s largest lender, as potential buyers for the stake.
-
5 days ago |
asiainsurancereview.com | Reva Ganesan
Nepal Insurance Authority (NEA) Chairman Sharad Ojha has instructed insurance companies to develop and implement robust policies, strategies, systems, and standards to combat money laundering.
-
5 days ago |
asiainsurancereview.com | Reva Ganesan
One of the two recently approved Alzheimer's drugs has been submitted for coverage under the National Health Insurance (NHI) programme and could be considered for inclusion by the end of the year, National Health Insurance Administration (NHIA) Director-General Shih Chung-liang announced The Far Eastern Memorial Hospital in New Taipei City announced that Kisunla—the brand name for donanemab, a monoclonal antibody developed by US pharmaceutical company Eli Lilly and Co—will be administered for...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →